Today, we announce a collaboration with Allegheny Health Network (AHN) to evaluate whether blood-based testing can inform #oncology providers on genetic variations within a patient’s cancer. “Partnering with AHN to help them perform testing within their system will further advance their institutional expertise in genomic cancer diagnosis and increase opportunities to match their patients with personalized therapy and improve patient outcomes,” said Phillip G. Febbo, MD Febbo, MD, Chief Medical Officer at Illumina. #Genomics4All #Illumina
“Our next moonshot is the $100 genome, a huge goal that really rallies everybody together and turns the innovation dials all the way up.” Hear more from Illumina’s VP and Head of Open Innovation, Ashley Van Zeeland, PhD, MBA, as she shares how Illumina’s collaboration efforts are driving the next wave of genomics and aiding in expanding access with Fast Company. #Genomics4All
Employee Spotlight: Sergio Peisajovich - Associate Director, Scientific Research in Protein Engineering Career Journey in a Word: Impactful Sergio began his career at Illumina in 2009 as a staff scientist in the research department. Today, he leads a team of protein engineers working to further the research and development of novel protein reagents for next generation sequencing. Sergio has also taught genetics and protein sciences at the University of Toronto. Listen as Sergio shares the real world applications of protein-based technologies and what makes his career so rewarding.
In June of 2019, Baby Fitz was merely days old when his family received news of his rare genetic condition. Through Rapid Whole Genome Sequencing and successful gene therapy, Baby Fitz is still happy, healthy, and active nearly 3 years later. In honor of #DNADay, we invited Fitz and his family to throw the first pitch during the San Diego Padres vs. Los Angeles Dodgers baseball game at San Diego’s Petco Park on Sunday! Read more about Baby Fitz’s life-saving diagnosis here: https://bit.ly/3M9Q1nk
“Genomics is not only allowing us to diagnose diseases we couldn’t before – people used to suffer in silence with these diseases that we couldn’t even name – but it’s also allowing us to look forward to the future.” – Erika Allred, MD, UC San Diego & Rady Children’s Hospital Watch the full video in recognition of #DNAday and learn how unlocking the genome is key to better human health: https://bit.ly/3LijRWw
Happy #CustomerAppreciationDay to all of our amazing customers! Stowers Institute for Medical Research McGill Genome Centre CHI MEI MEDICAL CENTER Shanghai ISC
We are committed to expanding the access to genomics and increasing the diversity of genomics data to realize health equity for billions of people around the world. The launch of our first LATAM Illumina Solution Center in São Paulo, Brazil will support the growing adoption of #genomics solutions by partners and customers throughout Latin America. Read more: https://bit.ly/37Gbrt6
Genomics should be available to the many, not the few. On #WorldHealthDay, we are excited to share what we are doing to expand access to genomics through innovation: ✅ Reached a milestone of 1 billion lives covered by genomic testing ✅Funded 18 new genomic companies through Illumina for Startups ✅Committed $120 million to launch iHope™ Genetic Health, a partnership with Genetic Alliance to increase patient access to genomics globally ✅Expanded medical knowledge of the power of genomics to save lives with education efforts reaching 30,000 medical learners And that is just the beginning. Learn more in our latest Corporate Social Responsibility report: https://bit.ly/3xcXYDY #Genomics4All #IlluminaProud
Will a kidney transplant be successful? Right now, the risk of rejection is unpredictable. But Verici Dx is using #AI to create RNA signatures that correlate with injury, rejection, or graft-failure. #Genomics
Drive value for your #genomics startup by joining the Illumina Accelerator, now with two locations in SF Bay Area and Cambridge, UK. Apply by April 1st. Together, we'll advance breakthrough applications in genomics, including therapeutics, diagnostics, agriculture, synthetic biology, forensics, & direct-to-consumer applications. #Startups
